日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

关于如何调查和随访未分化外周炎症性关节炎的多国循证建议:整合系统文献研究和3E倡议中广泛的国际风湿病学家专家组的意见

Machado, P; Castrejon, I; Katchamart, W; Koevoets, R; Kuriya, B; Schoels, M; Silva-Fernández, L; Thevissen, K; Vercoutere, W; Villeneuve, E; Aletaha, D; Carmona, L; Landewé, R; van der Heijde, D; Bijlsma, J W J; Bykerk, V; Canhão, H; Catrina, A I; Durez, P; Edwards, C J; Mjaavatten, M D; Leeb, B F; Losada, B; Martín-Mola, E M; Martinez-Osuna, P; Montecucco, C; Müller-Ladner, U; Østergaard, M; Sheane, B; Xavier, R M; Zochling, J; Bombardier, C

Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines.

类风湿性关节炎滑膜成纤维细胞在促炎细胞因子的作用下产生可溶性白细胞介素-7受体

Badot V, Durez P, Van den Eynde B J, Nzeusseu-Toukap A, Houssiau F A, Lauwerys B R

Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate

皮下注射阿巴西普与静脉注射阿巴西普:一项针对甲氨蝶呤疗效不佳患者的IIIb期非劣效性研究

Genovese, M C; Covarrubias, A; Leon, G; Mysler, E; Keiserman, M; Valente, R; Nash, P; Simon-Campos, J A; Porawska, W; Box, J; Legerton, C 3rd; Nasonov, E; Durez, P; Aranda, R; Pappu, R; Delaet, I; Teng, J; Alten, R

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

细胞共刺激调节对未分化炎症性关节炎或极早期类风湿性关节炎患者的影响:阿巴西普的临床和影像学研究(ADJUST 试验)

Emery, P; Durez, P; Dougados, M; Legerton, C W; Becker, J-C; Vratsanos, G; Genant, H K; Peterfy, C; Mitra, P; Overfield, S; Qi, K; Westhovens, R

The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial

ARRIVE试验:在接受抗肿瘤坏死因子治疗后停药或直接换用阿巴西普治疗的类风湿性关节炎患者中,阿巴西普6个月的安全性和有效性评估

Schiff, M; Pritchard, C; Huffstutter, J E; Rodriguez-Valverde, V; Durez, P; Zhou, X; Li, T; Bahrt, K; Kelly, S; Le Bars, M; Genovese, M C

Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors

阿巴西普治疗既往未接受过甲氨蝶呤治疗的早期类风湿关节炎且预后不良患者的临床疗效和安全性

Westhovens, R; Robles, M; Ximenes, A C; Nayiager, S; Wollenhaupt, J; Durez, P; Gomez-Reino, J; Grassi, W; Haraoui, B; Shergy, W; Park, S-H; Genant, H; Peterfy, C; Becker, J-C; Covucci, A; Helfrick, R; Bathon, J

Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules

类风湿关节炎中肿瘤坏死因子α非依赖性疾病机制:英夫利昔单抗对类风湿结节影响的组织病理学研究

Baeten, D; De Keyser, F; Veys, E M; Theate, Y; Houssiau, F A; Durez, P

A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment

一项随机对照研究,旨在比较静脉注射甲泼尼龙冲击疗法和英夫利昔单抗对甲氨蝶呤治疗无效的活动性类风湿关节炎患者的短期临床和生物学效应。

Durez, P; Nzeusseu Toukap, A; Lauwerys, B R; Manicourt, D H; Verschueren, P; Westhovens, R; Devogelaer, J-P; Houssiau, F A

Effect of milk product deprivation on spondyloarthropathy

乳制品缺乏对脊柱关节病的影响

Appelboom, T; Durez, P

In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A

抗CD3单克隆抗体或细菌脂多糖在体内诱导白细胞介素10:环孢素A的差异性调节

Durez, P; Abramowicz, D; Gérard, C; Van Mechelen, M; Amraoui, Z; Dubois, C; Leo, O; Velu, T; Goldman, M